Webcasts of the EGAM 2015 plenary session are available for viewing
7 Apr 2015
The plenary session presented information on the evolving structure of the EORTC as well as the clinical research landscape and new forms of clinical research activities covering the full span from early clinical trials to survivorship. Exchanging views with other stakeholders and discussing the role of academia will be major highlights.
EGAM 2015 also marked a special celebration in honor of Françoise Meunier, Director General and her many significant contributions to the EORTC over the past two and a half decades.
Webcasts
General introduction, Roger Stupp
The patients perspectives and survival issues, Isabelle Lebrocquy
Cancer Management and Transatlantic cooperation, Richard Schilsky
The EORTC Charitable Trust, Diego du Monceau
EORTC future perspectives, Roger Stupp
Related News
Meet the new EORTC Board
9 Jul 2024
We are pleased to announce the release of the EORTC 2023 Annual Report
17 Jun 2024
Dr Denis Lacombe, EORTC CEO, appointed stakeholder co-chair of ACT EU advisory group
24 May 2024
Clinical Trials Day 2024: a Q&A on pragmatic clinical trials
20 May 2024
EORTC/EMA workshop suggests an international way forward for treatment optimisation studies
8 May 2024
EORTC’s Participation at the ESTRO Congress 2024
29 Apr 2024
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024
